# F/M Emerald Life Sciences Innovation ETF (LFSC): ETF Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/lfsc for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Emerald · Asset class: Equity - Strategy: Actively Managed · Inception: 2024-10-30 The F/M Emerald Life Sciences Innovation ETF (LFSC) strategically invests in pioneering life science enterprises. Its core objective is to identify companies that are well-positioned for substantial long-term growth and the creation of significant value. As an actively managed fund, LFSC benefits from a highly specialized and experienced team dedicated to conducting in-depth research into complex life sciences firms. The fund primarily targets U.S. equity securities, selecting those that demonstrate strong growth potential. Specific criteria for inclusion involve a company's leadership in t... ## Key Facts | Metric | Value | |---|---| | Price | $43.11 | | Expense Ratio | 0.79% | | Assets Under Management | $116.0M | | NAV | $42.12 | | Holdings Count | 0 | | Distribution Yield (TTM) | — | | Annual Distribution (TTM) | — /share | | Distribution Frequency | — | | 52-Week Range | $31.02 – $48.78 | | Beta | 0.94 | ## Frequently Asked Questions ### What does LFSC invest in? The F/M Emerald Life Sciences Innovation ETF (LFSC) strategically invests in pioneering life science enterprises. Its core objective is to identify companies that are well-positioned for substantial long-term growth and the creation of significant value. As an actively managed fund, LFSC benefits from a highly specialized and experienced team dedicated to conducting in-depth research into complex life sciences firms. The fund primarily targets U.S. equity securities, selecting those that demonstrate strong growth potential. Specific criteria for inclusion involve a company's leadership in technological advancement, its capacity for market disruption, or its innovative application of artificial intelligence. The expansive field of life sciences, as defined by the fund, encompasses various sectors including biotechnology, pharmaceuticals, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection is guided by a rigorous and extensive 10-step research framework. This meticulous process incorporates: Reviews of publicly accessible and external third-party information. Comprehensive peer reviews. Development of detailed financial and valuation models. In-house research and surveys. Direct engagement and interviews with company management, industry and medical experts, and supply chain representatives. Robust internal collaboration among the investment team. While its primary focus is on domestic equities, the fund retains the flexibility to allocate up to 20% of its capital to foreign companies, provided they are listed and traded on a U.S. exchange. ### What is the expense ratio of LFSC? F/M Emerald Life Sciences Innovation ETF (LFSC) charges an expense ratio of 0.79%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is LFSC? F/M Emerald Life Sciences Innovation ETF (LFSC) manages $116.0M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is LFSC actively managed or an index fund? LFSC is actively managed: the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (LFSC's is 0.79%) in exchange for the discretion to over- or under-weight positions. ### When was LFSC launched? F/M Emerald Life Sciences Innovation ETF (LFSC) launched in October 2024 and is managed by Emerald. ### How has LFSC performed? LFSC's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does LFSC pay a dividend? F/M Emerald Life Sciences Innovation ETF (LFSC) currently distributes little or no income. Trailing-twelve-month yield is —. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does LFSC pay dividends? F/M Emerald Life Sciences Innovation ETF pays dividends on its published schedule. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is LFSC's dividend yield? LFSC's trailing-twelve-month yield is —, calculated from the sum of dividends over the past year divided by the current price. ### When is LFSC's next ex-dividend date? LFSC hasn't announced its next ex-date yet. Once declared it'll appear at the top of the dividend history table on this page. ### How much will LFSC's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.79% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does LFSC charge its expense ratio? The expense ratio is deducted in tiny daily slices from LFSC's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does LFSC cost more than a fund like VOO? LFSC is actively managed (current expense ratio 0.79%). Active funds charge more than passive index trackers in exchange for the manager's discretion to over- or under-weight positions. The Cost Verdict card above tells you whether LFSC's fee is competitive for the active-management cohort. ### Are there cheaper alternatives to LFSC? The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as LFSC (0.79%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/lfsc - Distribution history: https://www.dividenddata.com/funds/lfsc/dividend - Holdings & diversification: https://www.dividenddata.com/funds/lfsc/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/lfsc/expenses - Peer comparison: https://www.dividenddata.com/funds/lfsc/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.